RCAT
Red Cat Holdings, Inc. · Industrials · Aerospace & Defense
$4.80
+1.48% today · -18.78% 1W
Oct 15 close or latest
ReadoutWhy it's moving
Outperforming without a clear catalyst yet
- RCAT +1.48% on the last session vs SPY −0.00%: +1.5 pts of stock-specific move.
- Market backdrop (Today): Core PPI m/m 1.3% vs 0.3% expected (hotter); Core Retail Sales m/m 0.9% vs 0.6% expected (stronger); S&P futures -0.08%, 10-year yield -3bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Activity & positioning
- Volume
- 1.5× its 20-day averagepace so far
- Short interest
- 26.7% of float · 5.9 days to cover
- Options volume
- —
- Implied volatility
- —
- Options-implied move
- —
Moved with
Defense ETF (ITA) +0.3% +0.3 pts vs SPY
Key facts
- Market cap
- $966.7M
- Held by institutions
- 59.0%
- 52-week range
- 5.77–18.78
- Analyst mean target
- —
- Next earnings
- Nov 12 est.
- Forward P/E
- -11.4
Recent events
Insider ▼
Jeffrey M Thompson (Chairman of the Board, CEO, Director, 10% owner) sold 150,000 shares ($1.2M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingAnalyst
Piper Sandler started coverage at Neutral, target $9.00Analyst
Evercore ISI Group started coverage at Outperform, target $15.00Insider ▼
Nicholas Reyland Jr Liuzza (Director) sold 65,000 shares ($552.5K), not under a 10b5-1 plan unplanned · filingInsider ▼
Jeffrey M Thompson (Chairman of the Board, CEO, Director, 10% owner) sold 150,000 shares ($1.6M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Nicholas Reyland Jr Liuzza (Director) sold 55,000 shares ($584.6K), not under a 10b5-1 plan unplanned · filingInsider ▼
Christopher R. Moe (Director) sold 30,000 shares ($310.6K), not under a 10b5-1 plan unplanned · filingAnalyst ▼
Needham maintained Buy, lowered target $20.00 → $15.00Analyst
HC Wainwright & Co. reiterated Buy, target $20.00Insider ▼
Jeffrey M Thompson (Chairman of the Board, CEO, Director, 10% owner) sold 150,000 shares ($1.3M) under a pre-arranged 10b5-1 plan 10b5-1 plan · filingInsider ▼
Paul Ii Funk (Director) sold 165,028 shares ($1.9M), not under a 10b5-1 plan unplanned · filingAnalyst
Roth Capital started coverage at Buy, target $25.00